← Leaderboards
Mireia Guerau-De-Arellano
Ohio State University
$2,960,533
Attributed
$3,166,884
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $659.8K · FY2012–21$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,166,884 · 4
By mechanism
R01$2,194,640 · 1
R21$816,244 · 2
R03$156,000 · 1
Top collaborators
- Phillip G Popovich2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Said Sif$3,929,512
- Amy E Lovett-Racke$7,052,190
- Brian M Ahmer$8,104,453
- Michael K Chan$2,906,549
- Steven K Clinton$5,749,067
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryPharmaceutical PreparationsPhenotypeMediatingDisabilityNeuraxisCellsLoss Of FunctionEnzymesMultiple SclerosisYoung AdultMolecularResponseInhibitor/AntagonistT-LymphocyteOhioExperimental Autoimmune EncephalomyelitisPathologyMouse ModelUniversitiesEnvironmentInnovationAutoimmune ProcessCytokine
Grant awards (11)
Novel knockout models to analyze CD38 function$78,000
R03 · FY2021 · AI · contact PI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity$438,928
R01 · FY2020 · AI · contact PI
Novel knockout models to analyze CD38 function$78,000
R03 · FY2020 · AI · contact PI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity$438,928
R01 · FY2019 · AI · contact PI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity$438,928
R01 · FY2018 · AI · contact PI
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple Sclerosis$182,666
R21 · FY2018 · AI · contact PI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity$438,928
R01 · FY2017 · AI · contact PI
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple Sclerosis$220,875
R21 · FY2017 · AI · contact PI
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity$438,928
R01 · FY2016 · AI · contact PI
miRNA Regulation of Macrophages after Spinal Cord Injury$183,953
R21 · FY2013 · NS
miRNA Regulation of Macrophages after Spinal Cord Injury$228,750
R21 · FY2012 · NS